Evaluation of xenogeneic CAR-T cell therapy for canine CD20+ B cell lymphoma
|Effective start/end date||3/15/22 → 4/30/24|
- LIFENGINE ANIMAL HEALTH LABS, INC
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.